MedPath

Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy

Completed
Conditions
Acute Leukemia
Registration Number
NCT03279900
Lead Sponsor
Indonesia University
Brief Summary

This study use an observational study design from patient medical records to obtain data on patient demographics, nutritional status, 6MP dosing, and albumin levels of LLA child patients.

Detailed Description

All medical record data of LLA child patient at maintenance phase therapy, who came to Cipto Mangunkusumo Kiara Hospital in period 2014 - 2016. the data that are colected consist of age, gender, disease stratification, nutritional status, the dosage of 6-MP, albumin levels, hemoglobin levels, leukocyite counts, platelet counts, and absolute neutrophil counts.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • LLA Patients, male and female, age 1 - <18 years
  • Received chemotherapy maintenance phase based on Indonesian protocol of ALL - 2013
Exclusion Criteria
  • Incomplete medical record data.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Incidence of hematotoxicity in acute limphoblastic leukemia children during maintenance phase therapy.october 2017

based on medical record data: Incidence of anemia, Neutropenia, and thrombocytopenia in acute limphoblastic leukemia children during maintenance phase therapy.

Secondary Outcome Measures
NameTimeMethod
The relationship of the incidence of hematotoxicity with influencing factorsNovember 2017

The relationship of the incidence of hematotoxicity (anemia, Neutropenia, thrombocitopenia) with ALL stratification (High risk or Standard risk, as written in the medical record), nutritional status (normal or malnutrition), and albumin levels (normal or Hypoalbuminemia). The determination of nutritional status is based on body weight (Kg) and Height (Meters). Determination of nutritional status using cutoff Z score based on The growth chart of WHO 2006 for children 0-5 years, and ideal weight percentage according to Waterlow criteria for children above 5 years (recommendation of Indonesian Pediatric Association).

Trial Locations

Locations (1)

Cipto Mangunkusomo hospital

🇮🇩

Jakarta Pusat, Jakarta, Indonesia

© Copyright 2025. All Rights Reserved by MedPath